NCT01558908View on ClinicalTrials.gov

Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions
Peripheral Vascular Diseases
Interventions
BIOLOGICAL

Administration of ERC

Patients will be treated with either 25 million, 50 million, or 100 million ERC by intramuscular injection.

Trial Locations (1)

Unknown

Indiana University School of Medicine, Indianapolis

Sponsors

Lead Sponsor

Medistem Inc.
All Listed Sponsors
lead

Medistem Inc.

INDUSTRY